Substituted benzenediol Schiff bases as promising new anti-glycation agents

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 26, Issue 1, 2011, Pages 98-103

  Choudhary, M Iqbal ^a   Abbas, Ghulam ^a   Ali, Saqib ^b   Shuja, Shaukat ^b   Khalid, Nasir ^c   Khan, Khalid M ^a   Atta Ur Rahman, ^a   Basha, Fatima Z ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

^c PAKISTAN INSTITUTE OF NUCLEAR SCIENCE AND TECHNOLOGY   (Pakistan)

Author keywords

AGEs; anti glycation agents; benzenediol Schiff bases; structure activity relationships

Indexed keywords

3 [(2 CHLOROPHENYLIMINO)METHYL]BENZENE 1,2 DIOL; 3 [(3 CHLOROPHENYLIMINO)METHYL]BENZENE 1,2 DIOL; 3 [(3 TRIFLOUROMETHYLPHENYLIMINO)METHYL] BENZENE 1,2 DIOL; 3 [(4 BROMOANILINO)METHYL]1,2 BENZENEDIOL; 3 [(4 BROMOPHENYLIMINO)METHYL]BENZENE 1,2 DIOL; 3 [(4 CHLOROPHENYLIMINO)METHYL]BENZENE 1,2 DIOL; 3 [[(2,4 DICHLOROPHENYL)IMINO]METHYL]1,2 BENZENEDIOL; ADVANCED GLYCATION END PRODUCT; BENZENE DERIVATIVE; CYCLOHEXIMIDE; RUTOSIDE; SCHIFF BASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGLYCATION ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; FIBROBLAST; GLYCATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECTROFLUOROMETRY; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

3T3 CELLS; ANIMALS; BENZENE DERIVATIVES; BLOOD GLUCOSE; DIABETES COMPLICATIONS; FLUORESCENCE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MAILLARD REACTION; MICE; SCHIFF BASES; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79851503904     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756361003733621     Document Type: Article

References (21)

1. Reddy VP and Beyaz A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discovery Today 2006;11:13-14.
2. Sakai M, Oimomi M and Kasuga M, Kobe J. Experimental studies on the role of fructose in the development of diabetic complications. Med Sci 2002;48:125-136. (Pubitemid 36693092)
3. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001;44:129-146. (Pubitemid 32156196)
4. Bendayan M. Immunocytochemical detection of advanced glycated endproducts in rat renal tissues as a function of age and diabetes. Kidney Int 1998;54:438-447. (Pubitemid 28357406)
5. Vlassara H. Advanced glycation in health and disease: role of the modern environment. Ann NY Acad Sci 2005;1043:452-460. (Pubitemid 41123933)
6. Wautier JL, Guillausseau PJ. Advanced glycation endproducts, their receptors and diabetic angiopathy. Diabetes Metab (Paris) 2001;27:535-542. (Pubitemid 33051702)
7. Atta-ur-Rahman, Choudhary MI, Basha FZ, Abbas G, Khan SN, Ali S. A, Science at the interface of chemistry and biology: Discoveries of a-glucosidase inhibitors and antiglycation agents. Pure Appl Chem. 2007;79:2263-2268.
8. Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy aminoguanidine and aspirin. Diabetes 2001;50:1636-1642. (Pubitemid 33639605)
9. Sell DR, Nelson J F, Monnier VM. Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice. J Gerontol (A Biol Sci Med Sci) 2001;56:B405-B411.
10. Taguchi T, Sugiura M, Hamada Y, Miwa I. Inhibition of advanced protein glycation by a Schif base between aminoguanidine and pyridoxal. Eur J Pharmacol 1999;378: 283-289. (Pubitemid 29392929)
11. Khan KM, Mughal UR, Ambreen N, Khan A, Perveen S, Choudhary MI. Schif Bases of Istain: Antiglycation activity. Lett Drug Des Discov 2009;6:358-362.
12. Laurean DC, Schramm DD, Jacobson EL, Halaweish I, Bruckner GG, Boissonneault GA. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J Nutr Biochem 2006;17:531-40. (Pubitemid 44066765)
13. Wu CH, Yen GC. Inhibitory efect of naturally occurring favonoids on the formation of advanced glycation endproducts. J Agric Food Chem 2005;20:3167-73.
14. Choudhary MI, Jan S, Abbaskhan A, Musharraf SG, Samreen, Sattar SA, Atta-ur-Rahman. Cycloartane triterpenoids from Astragalus bicuspis. J Nat Prod 2008;71:1557-1560.
15. Matsuda H, Wang T, Managi H, Yoshikawa M. Structural requirements of favonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 2003;11:5317-5323. (Pubitemid 37464658)
16. Duraisamy Y Gafney J, Selvin M, Smith CA, Williamson K, Ahmed N. Aminosalicylic acid reduces the antiproliferative efect of hyperglycaemia, advanced glycation endproducts and glycated basic fbroblast growth factor in cultured bovine aortic endothelial cells: Comparison with aminoguanidine. Mol Cell Biochem 2003;246:143-153. (Pubitemid 36798735)
17. Matsuura N, Aradate T, Sasaki C, Kojima H, Ohara M, Hasegawa J, Ubukata M. Screening system for the Maillard reaction inhibitor from natural products extracts. J Health Sci 2002;48:520-526. (Pubitemid 41301505)
18. Nakagawa T, Yokozawa T, Terasawa K, Shu S, Juneja LR. Protective activity of green tea against free radical-and glucose-mediated protein damage. J Agric Food Chem 2002;50:2418-2422. (Pubitemid 34275319)
19. Nicholl ID, Bucala R. Advanced glycation endproducts and cigarette smoking. Cell Mol Biol 1998;44:1025-1033.
20. Kim HY Kim K. Protein glycation inhibitory and antioxidative activities of some plant extracts in vitro. J Agric Food Chem 2003;51: 1586-1591.
21. Kara D, Alkan M. Preconcentration and separation of copper (II) with solvent extraction using N,N'-bis(2-hydroxy-5-bromo-benzyl)1,2 diaminopropane. Microchem J 2002;71:29-39.